These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34800005)
1. The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ-Ⅲ esophageal cancer: a SEER-based demographic analysis. Lv H; Chao C; Wang B; Wang Z; Qian Y; Zhang X Cancer Med; 2021 Dec; 10(23):8483-8496. PubMed ID: 34800005 [TBL] [Abstract][Full Text] [Related]
2. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis. Hong JC; Murphy JD; Wang SJ; Koong AC; Chang DT Ann Surg Oncol; 2013 Nov; 20(12):3999-4007. PubMed ID: 23800897 [TBL] [Abstract][Full Text] [Related]
3. Prognostic evaluation of esophageal cancer patients with stages I-III. Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062 [TBL] [Abstract][Full Text] [Related]
4. Treatment Modalities for Esophageal Adenocarcinoma in the United States: Trends and Survival Outcomes. Di Corpo M; Schlottmann F; Strassle PD; Nurczyk K; Patti MG J Laparoendosc Adv Surg Tech A; 2019 Aug; 29(8):989-994. PubMed ID: 31246532 [No Abstract] [Full Text] [Related]
6. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus. Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492 [TBL] [Abstract][Full Text] [Related]
7. Conditional survival in patients with esophageal or gastroesophageal junction cancer after receiving various treatment modalities. Deng W; Yang Z; Dong X; Yu R; Wang W Cancer Med; 2021 Jan; 10(2):659-674. PubMed ID: 33314798 [TBL] [Abstract][Full Text] [Related]
8. Is postoperative adjuvant radiotherapy necessary for patients with esophageal cancer after neoadjuvant chemoradiotherapy? An analysis based on the SEER database. An Q; Su Y; Wang Y; Zhen C; Bai W; Fu L; Liu Y; Zhang P; Zhou Z Saudi Med J; 2024 Aug; 45(9):900-910. PubMed ID: 39218457 [TBL] [Abstract][Full Text] [Related]
9. Treatment patterns and survival in T4b esophageal cancer: a retrospective cohort study. Yu BB; Huang JQ; Liang HW; Liu Y; Chen L; Pei S; Huang W; Pan XB Aging (Albany NY); 2024 Apr; 16(8):7131-7140. PubMed ID: 38643464 [TBL] [Abstract][Full Text] [Related]
10. Prognostic analysis and treatment utilization of different treatment strategies in elderly esophageal cancer patients with distant metastases: a SEER database analysis. Han LQ; Cui TT; Xiao NJ; Li W J Cancer Res Clin Oncol; 2023 Nov; 149(17):15413-15423. PubMed ID: 37644234 [TBL] [Abstract][Full Text] [Related]
11. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma. Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309 [TBL] [Abstract][Full Text] [Related]
12. Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis. Eil R; Diggs BS; Wang SJ; Dolan JP; Hunter JG; Thomas CR Cancer; 2014 Feb; 120(4):492-8. PubMed ID: 24194477 [TBL] [Abstract][Full Text] [Related]
13. Survival benefit of combined immunotherapy and chemoradiotherapy in locally advanced unresectable esophageal cancer: an analysis based on the SEER database. Xie L; Zhang Z Front Immunol; 2024; 15():1334992. PubMed ID: 38292873 [TBL] [Abstract][Full Text] [Related]
14. Influence of adverse effects of neoadjuvant chemoradiotherapy on the prognosis of patients with early-stage esophageal cancer (cT1b-cT2N0M0) based on the SEER database. Cao X; Wu B; Li H; Xiong J Front Surg; 2023; 10():1131385. PubMed ID: 37143768 [TBL] [Abstract][Full Text] [Related]
15. Role of Perioperative Chemotherapy in Lymph Node-negative Esophageal Cancer After Resection: A Population-based Study With Propensity Score-matched Analysis. Yang Y; Zhou X; Tang L; Xu X; Du X; Qiu G Am J Clin Oncol; 2019 Dec; 42(12):924-931. PubMed ID: 31651453 [TBL] [Abstract][Full Text] [Related]
16. Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal Cancer. Faiz Z; van Putten M; Verhoeven RHA; van Sandick JW; Nieuwenhuijzen GAP; van der Sangen MJC; Lemmens VEPP; Wijnhoven BPL; Plukker JTM Ann Surg Oncol; 2019 Apr; 26(4):986-995. PubMed ID: 30719634 [TBL] [Abstract][Full Text] [Related]
17. Curative treatment for esophageal cancer: Vancouver Island Cancer Centre experience from 1993 to 1998. Wilson KS; Wilson AG; Dewar GJ Can J Gastroenterol; 2002 Jun; 16(6):361-8. PubMed ID: 12096299 [TBL] [Abstract][Full Text] [Related]
18. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Wani S; Drahos J; Cook MB; Rastogi A; Bansal A; Yen R; Sharma P; Das A Gastrointest Endosc; 2014 Feb; 79(2):224-232.e1. PubMed ID: 24060519 [TBL] [Abstract][Full Text] [Related]
19. Esophageal Cancer Treatment Is Underutilized Among Elderly Patients in the USA. Molena D; Stem M; Blackford AL; Lidor AO J Gastrointest Surg; 2017 Jan; 21(1):126-136. PubMed ID: 27527093 [TBL] [Abstract][Full Text] [Related]
20. Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis. Li J; Jia Y; Cheng Y; Wang J Cancer Med; 2020 Jul; 9(14):5025-5034. PubMed ID: 32441890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]